A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductions.
暂无分享，去创建一个
P. Vici | N. Petragnani | A. Costantini | F. D. Vita | F. Santoleri | M. Zeuli | R. Lasala | Antonia Marina La Malfa | M. Pasquantonio | F. Musicco | M. Sansone | A. Romagnoli | P. Abrate | Maria Teresa Carretta | E. M. Proli | Chiara Fulgenzio